Financials in USD. Standardized financial statements.
A compact view of how Crescent Biopharma, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $10.84M | $0 | $10,000 | $75,000 | $1.16M | $10.16M | $0 | $0 | $0 | $18,500 |
| Revenue Growth? | 0.0% | -100.0% | -86.7% | -93.5% | -88.6% | 0.0% | 0.0% | 0.0% | -100.0% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $0 | $0 | $899,302 | $275,123 | $263,541 | $0 |
| Gross Profit? | $10.84M | $0 | $10,000 | $75,000 | $1.16M | $0 | -$899,302 | -$275,123 | -$263,541 | $0 |
| Gross Margin? | +100.0% | 0.0% | +100.0% | +100.0% | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $163.48M | $49.90M | $39.29M | $47.48M | $64.61M | $61.67M | $61.39M | $51.51M | $33.67M | $31.93M |
| Operating Income? | -$152.63M | -$49.90M | -$39.28M | -$47.40M | -$63.45M | -$51.51M | -$61.39M | -$51.51M | -$33.93M | -$31.91M |
| EBITDA? | -$149.67M | -$44.17M | -$39.12M | -$47.20M | -$63.18M | -$51.24M | -$56.99M | -$51.23M | -$33.67M | -$31.72M |
| Income Before Tax | -$151.94M | -$48.52M | -$36.90M | -$46.69M | -$63.43M | -$51.03M | -$57.89M | -$48.27M | -$33.28M | -$31.81M |
| Income Tax Expense | $2.00M | $0 | $0 | $0 | $0 | $0 | -$3.78M | $3.23M | $0 | $0 |
| Net Income? | -$153.94M | -$48.52M | -$36.90M | -$46.69M | -$63.43M | -$51.03M | -$54.12M | -$48.27M | -$33.28M | -$31.81M |
| EPS? | $-14.78 | $-1.40 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | $-1.18 | $-1.13 | $-1.50 |
| Diluted EPS? | $-14.78 | $-1.40 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | $-1.18 | $-1.13 | $-1.50 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality